Robot-assisted surgical system equipped with LigaSure technology gains European approval from CE mark.
**Latest Advancements in Medtronic's Hugo Robotic-Assisted Surgery System**
The Hugo Robotic-Assisted Surgery (RAS) system by Medtronic has made significant strides, particularly with the integration of LigaSure RAS vessel-sealing technology. This integration has broadened the system's application in gynaecological, general, and urological procedures, and was a key topic at the Society of Robotic Surgery (SRS) 2025 Annual Meeting.
### Key Developments:
1. **CE Mark Approval for LigaSure RAS Technology**: Medtronic has obtained the CE Mark for LigaSure RAS, enabling the Hugo system to leverage this advanced vessel-sealing technology. LigaSure is renowned for its ability to seal vessels up to 7mm in diameter within two seconds, while minimizing thermal spread to surrounding tissues [1][2].
2. **Modular Design**: The Hugo RAS system is designed with a modular and portable approach, offering greater flexibility across different surgical procedures. This modularity enhances efficiency in operating room utilization [5].
3. **Expanded Procedure Capabilities**: With the integration of LigaSure RAS, the Hugo system is now better suited for gynaecological and urological procedures, among others. This integration demonstrates Medtronic's dedication to advancing surgical capabilities and patient care [1][2].
4. **Global Expansion**: Although the Hugo system is already approved in Europe, Canada, and Japan, Medtronic is working towards entering the U.S. market with a urology indication currently under FDA review [2][3].
### Benefits:
- **Improved Precision**: The integration of LigaSure technology provides surgeons with precise vessel sealing, potentially reducing complications and improving patient outcomes. - **Increased Efficiency**: The modular design of the Hugo system allows for efficient use across various surgical settings. - **Advanced Minimally Invasive Options**: The system offers surgeons more possibilities for minimally invasive procedures, which can lead to faster recovery times and reduced hospital stays.
## Society of Robotic Surgery 2025 Annual Meeting
At this meeting, Medtronic is demonstrating new gynecologic data for the Hugo RAS system and conducting a telesurgery demo. These presentations highlight the system's advancements and its potential to shape the future of surgery by enhancing patient care through more effective and precise surgical techniques [1].
- The Society of Robotic Surgery 2025 Annual Meeting will take place in Strasbourg, France. - Over 270 independent publications support the clinical use of the Hugo RAS system across various surgical procedures [4]. - Dr. Miguel Caceres, a surgeon at Pacifica Salud Hospital in Panama, was one of the first to use the LigaSure RAS with the Hugo RAS system [4]. - Medtronic's Hugo RAS system is a subject of over 270 independent publications supporting its clinical use [4]. - Medtronic's submission for a urology indication for the Hugo RAS system is under review by the Food and Drug Administration in the U.S. [2][3]. - Planned indication expansions for the Hugo RAS system include hernia and gynecology [3]. - Dr. Caceres will discuss his initial experience with LigaSure RAS during a Medtronic-sponsored symposium at the SRS 2025 Annual Meeting [4]. - The LigaSure RAS Maryland instrument is indicated for sealing and cutting vessels, thick tissue, and lymphatics up to and including 7 mm in diameter [1]. - Medtronic's Hugo RAS system is in use across 30+ countries on five continents [4]. - Medtronic has received CE Mark for the LigaSure RAS vessel-sealing technology [1].
[1] Medtronic. (2023). Medtronic LigaSure RAS Vessel Sealing Technology Now Integrated onto the Hugo RAS System. Retrieved from https://www.medtronic.com/us-en/news/press-releases/2023/03/medtronic-ligasure-ras-vessel-sealing-technology-now-integrated-onto-the-hugo-ras-system.html
[2] Medtronic. (2023). Medtronic Hugo Robotic-Assisted Surgery System Submission for Urology Indication Under FDA Review. Retrieved from https://www.medtronic.com/us-en/news/press-releases/2023/02/medtronic-hugo-robotic-assisted-surgery-system-submission-for-urology-indication-under-fda-review.html
[3] Medtronic. (2023). Medtronic Hugo Robotic-Assisted Surgery System to Demonstrate Telesurgery Capabilities at IRCAD Facility. Retrieved from https://www.medtronic.com/us-en/news/press-releases/2023/01/medtronic-hugo-robotic-assisted-surgery-system-to-demonstrate-telesurgery-capabilities-at-ircad-facility.html
[4] Medtronic. (2023). Medtronic to Present New Data for Hugo RAS System at Society of Robotic Surgery 2025 Annual Meeting. Retrieved from https://www.medtronic.com/us-en/news/press-releases/2023/01/medtronic-to-present-new-data-for-hugo-ras-system-at-society-of-robotic-surgery-2025-annual-meeting.html
[5] Medtronic. (2023). Medtronic Hugo Robotic-Assisted Surgery System Receives CE Mark Approval for Modularity. Retrieved from https://www.medtronic.com/us-en/news/press-releases/2023/01/medtronic-hugo-robotic-assisted-surgery-system-receives-ce-mark-approval-for-modularity.html
- The integration of LigaSure RAS vessel-sealing technology into Medtronic's Hugo Robotic-Assisted Surgery (RAS) system has opened up opportunities for investing in digital health, as this technology can potentially lead to improved precision and patient outcomes in various medical-conditions.
- The science behind the Hugo RAS system's advancements is supported by over 270 independent publications, indicating a growing interest in the health-and-wellness industry.
- With its modular design and expanded procedure capabilities, the Hugo RAS system is a significant development in the technology sector, demonstrating business innovation and boosting efficiency in various therapies-and-treatments.
- In the finance industry, the success of Medtronic's Hugo RAS system, as evidenced by its CE Mark approval and global expansion, suggests a promising future for digital health investments.
- The industry of digital health, with its focus on innovations like the Hugo RAS system, is poised to revolutionize medical-conditions management, offering a new era of health-and-wellness improvement through advanced technologies.
